Although the cell and molecular signature is distinct between MPN subtypes, these overlap on the signaling pathways and regulatory proteins level, such as STAT, NFκB and/or HIF-1α [20,21,22]. The gene discussed is NFKB1; the disease is myeloproliferative disorder.